Table 4 Distribution and frequency of Estimated endpoint titer by sex, and age.

From: Mapping of the Antinuclear Autoantibodies in Sudanese patients infected with Human Immunodeficiency Virus after HAART receiving: A cross-sectional study

Characteristics

1:80 (cutoff)

45 (52.9%)

1:160

5 (8.9%)

1:320

23 (27.1%)

1:640

10 (11.8%)

1:1280

2 (2.4%)

p-value

Male

31 (68.9%)

2 (40%)

11 ( 47.8%)

4 (40%)

1 (50%)

0.10

Female

14 (31.1%)

3 ( 60%)

12 ( 52.2%)

6 (60%)

1 (50%)

 ≤ 25

6 (13.3%)

1 ( 20%)

6 ( 26.1%)

2 (20%)

-

0.54

26–41

22 (48.9%)

1 (20%)

12 ( 52.2%)

6 ( 60%)

1 (50%)

42–56

12 (26.7%)

3 ( 60%)

4 (17.4%)

1 ( 20%)

-

 ≥ 57

5 ( 11.1%)

-

2 ( 8.7%)

-

1 (50%)

Back to article page